Peds CNS - Medulloblastoma
Автор: Rad Onc Talks
Загружено: 2025-05-14
Просмотров: 1403
Medulloblastoma is the most common malignant brain tumor in pediatric patients with a high rate of drop metastases to the spinal cord. As such, is managed aggressively with maximal safe resection followed by craniospinal irradiation with a boost. Dosing and boost volume are based on clinical risk group, and currently medulloblastoma is divided into average vs. standard risk based on the age, stage, histology, and extent of resection. In the future, risk groups will likely be more tailored based on molecular risk profile as well. In this talk, we discuss the background, staging, treatment, and some of the evidence base behind the management of medulloblastoma.
This presentation is created purely for educational purposes and does NOT constitute medical advice. If there are any errors or questions/concerns, we welcome comments and discussion!
Join the Rad Onc Study Club to get access to mock oral board style case reviews!
/ @rad_onc_talks
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
